Commercial Channels

With new cellular and genetic therapies, the reimbursement process will need to evolve

Connecting with buying influences in integrated delivery networks is a challenge

14th edition attracted 59 commercial plans as respondents, representing 100 million lives

Company celebrates its growth at annual industry event

Specialty-pharma support providers have a potential benefit in behavioral targeting insights

Company offers a risk-mitigation analytics suite to enable pharma monitoring

While nominal spending was up 1.4%, actual net spending was only 0.6% greater than 2016

Vaccines for adult disease states and for tropical diseases expand the market beyond traditional pediatric applications

Speed to therapy is a benefit

Existing ‘pay for performance’ models do not scale up well yet

Patient support (hub) services rise in lockstep with specialty pharmaceutical launches

Data drawn from collaborating sources can benefit the patient journey

Hub services enhance relationships with patients

Forecast is for 3-6% CAGR through 2022

Growing emphasis on machine learning for improving data quality

High prices and questionable marketing activities muddy an otherwise bright picture

Analysis finds healthcare policy benefits among distinct groupings of drugs

A mix of high-tech and high-touch interventions address one of healthcare’s most pressing issues

Accenture research shows heightened consumer awareness, and boomer/millennial differences

Company emphasizes its clinical-to-commercial scope

Adds to company’s Forecasting Practice

Orchestrated Customer Engagement (OCE) breaks down functional silos in commercial operations

IQVIA’s eighth annual survey shows 77% of respondents go beyond compliance reporting